Public annual accounts

Apotheek Yves Tarnaud financials

Name: Apotheek Yves Tarnaud financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for Apotheek Yves Tarnaud, with comparable measures and links to available source documents.

Company overview

Registry number

0859602023

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 29, 2026

Financial evidence

Latest movements for Apotheek Yves Tarnaud

2025 versus 2024

Operating line: €204,685
EBITDA: €200,369
Total assets: €338,407
Equity: €24,685

EBITDA margin +97.9% · Equity ratio +7.3%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202531 Dec 2025	€204,685	€200,369	€338,407	€24,685	-
202431 Dec 2024	€245,088	€240,896	€488,435	€142,929	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report

Fiscal year

Gross margin

EBITDA

Total assets

Equity

Filing

202531 Dec 2025

€204,685

€200,369

€338,407

€24,685

202431 Dec 2024

€245,088

€240,896

€488,435

€142,929